ArticleNanoscale advances2020
3D multiphoton lithography using biocompatible polymers with specific mechanical properties.
Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Hybrid Multiphoton Lithography Scaffolds for Nanoscale Mechanobiological Assessment in Microscale Bone Models.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Methodological innovations in perfusable vascular networks: Advancing high-density tissue models.Regenerative therapy · 2026Article
- Quantifying cell traction forces at the single-fiber scale in 3D: An approach based on deformable photopolymerized fiber arrays.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- 3D Multiphoton Nanolithography with Bioresorbable Amino Acid-Based Resins.Nano letters · 2025Article
- Two-photon absorption under few-photon irradiation for optical nanoprinting.Nature communications · 2025Article
- Site-Selective Biofunctionalization of 3D Microstructures Via Direct Ink Writing.Small (Weinheim an der Bergstrasse, Germany) · 2024Article
- Phosphoramide Hydrogels as Biodegradable Matrices for Inkjet Printing and Their Nano-Hydroxyapatite Composites.ACS applied materials & interfaces · 2024Article
- Multiphoton lithography with protein photoresists.Materials today. Bio · 2024Article
- New buffer systems for photopainting of single biomolecules.RSC applied interfaces · 2024Article
- Biomaterial-basedCancer pathogenesis and therapy · 2023Review
- Amino Acid-Based Polyphosphorodiamidates with Hydrolytically Labile Bonds for Degradation-Tuned Photopolymers.ACS macro letters · 2023Article
- Biocompatible polymers with tunable mechanical properties and conductive functionality on two-photon 3D printing.RSC advances · 2023Article
- Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases.Biosensors · 2022Review
- Assessment of Efficacy of a Novel Crosslinking Protocol with Intracameral Oxygen (Bubble-CXL) in Increasing the Corneal Stiffness Using Atomic Force Microscopy.Nanomaterials (Basel, Switzerland) · 2022Article
- Thermal, Mechanical and Biocompatibility Analyses of Photochemically Polymerized PEGDAPharmaceutics · 2022Article
- Long-Time Behavior of Surface Properties of Microstructures Fabricated by Multiphoton Lithography.Nanomaterials (Basel, Switzerland) · 2021Article
- An Improved Transwell Design for Microelectrode Ion-Flux Measurements.Micromachines · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The fabrication of two- and three-dimensional scaffolds mimicking the extracellular matrix and providing cell stimulation is of high importance in biology and material science. We show two new, biocompatible polymers, which can be 3D structured
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.